NCT00988598View on ClinicalTrials.gov

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 26, 2009

Primary Completion Date

July 5, 2010

Study Completion Date

July 5, 2010

Conditions
Alzheimer's Disease
Interventions
DRUG

PF-04447943

25 mg of PF-04447943 orally every 12 hours for 7 days

DRUG

Placebo

25 mg matching placebo to PF-04447943 orally every 12 hours for 7 days

Trial Locations (3)

32608

University of Florida - Center for Clinical Trials Research, Gainesville

33009

MD Clinical, Hallandale

91206

Glendale Adventist Medical Center, Glendale

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00988598 - A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter